Literature DB >> 32246779

EAT-10 Scores and Fiberoptic Endoscopic Evaluation of Swallowing in Head and Neck Cancer Patients.

Michelle Florie1, Walmari Pilz1,2, Bernd Kremer1,2, Femke Verhees1, Ghislaine Waltman1, Bjorn Winkens3, Naomi Winter1, Laura Baijens1,2.   

Abstract

OBJECTIVE: The purpose of this study was to determine the relationship between patient-reported symptoms of oropharyngeal dysphagia (OD) using the Eating Assessment Tool (EAT)-10 and the swallowing function using a standardized fiberoptic endoscopic evaluation of swallowing (FEES) protocol in head and neck cancer (HNC) patients with confirmed OD.
METHODS: Fifty-seven dysphagic HNC patients completed the EAT-10 and a FEES. Two blinded clinicians scored the randomized FEES examinations. Exclusion criteria consisted of presenting with a concurrent neurological disease, scoring below 23 on a Mini-Mental State Examination, being older than 85 years, having undergone a total laryngectomy, and being illiterate or blind. Descriptive statistics, linear regression, sensitivity, specificity, and predictive values were calculated.
RESULTS: The majority of the dysphagic patients (N = 38; 66.7%) aspirated after swallowing thin liquid consistency. A large number of patients showed postswallow pharyngeal residue while swallowing thick liquid consistency. More specifically, 42 (73.0%) patients presented postswallow vallecular residue, and 39 (67.9%) patients presented postswallow pyriform sinus residue. All dysphagic patients had an EAT-10 score ≥ 3. Linear regression analyses showed significant differences in mean EAT-10 scores between the dichotomized categories (abnormal vs. normal) of postswallow vallecular (P = .037) and pyriform sinus residue (P = .013). No statistically significant difference in mean EAT-10 scores between the dichotomized categories of penetration or aspiration was found (P = .966).
CONCLUSION: The EAT-10 questionnaire seems to have an indicative value for the presence of postswallow pharyngeal residue in dysphagic HNC patients, and a value of 19 points turned out to be useful as a cutoff point for the presence of pharyngeal residue in this study population. LEVEL OF EVIDENCE: 2B.
© 2020 The Authors. The Laryngoscope published by Wiley Periodicals, Inc. on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Dysphagia, deglutition, deglutition disorders, EAT-10, head and neck cancer

Year:  2020        PMID: 32246779     DOI: 10.1002/lary.28626

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Trans-Adaptation and Analysis of Psychometric Properties of Hindi Version of Eating Assessment Tool-10 (EAT-10H).

Authors:  Himanshu Verma; Harleen Kaur; Philemon Benison; Madishetty Harisha; Janaki Balaji
Journal:  Dysphagia       Date:  2022-07-10       Impact factor: 2.733

Review 2.  Oral Health Management and Rehabilitation for Patients with Oral Cancer: A Narrative Review.

Authors:  Yuhei Matsuda; Ruwan D Jayasinghe; Hui Zhong; Shinichi Arakawa; Takahiro Kanno
Journal:  Healthcare (Basel)       Date:  2022-05-23

3.  Asymptomatic swallowing disorders may be present in individuals with laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy.

Authors:  César Álvarez-Marcos; Andrea Vicente Benito; Agueda Gayol Fernández; Daniel Pedregal-Mallo; Paloma Sirgo Rodríguez; Liliana Santamarina Rabanal; José Luis Llorente; Fernando López; Juan Pablo Rodrigo
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-07       Impact factor: 2.503

4.  Validation and Cultural Adaptation of an Arabic Version of Pediatric Eating Assessment Tool (Pedi-EAT-10Arabic).

Authors:  Sally M Adel; Alaa H Gaafar; Nader Fasseeh; Rania M Abdou; Nesrine Hazem Hamouda
Journal:  Dysphagia       Date:  2022-01-11       Impact factor: 3.438

5.  Patient Reported Outcomes and Objective Swallowing Assessments in a Multidisciplinary Dysphagia Clinic.

Authors:  Karuna Dewan; John O Clarke; Afrin N Kamal; Monica Nandwani; Heather M Starmer
Journal:  Laryngoscope       Date:  2020-10-26       Impact factor: 2.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.